Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiplex targeted high-throughput sequencing for Mendelian cardiac disorders.

Clinical genetics - 1 Apr 2014

Fokstuen S, Makrythanasis P, Nikolaev S, Santoni F, Robyr D, Munoz A, Bevillard J, Farinelli L, Iseli C, Antonarakis S E, Blouin J-L

Abstract excerpt

Mendelian cardiomyopathies and arrhythmias are characterized by an important genetic heterogeneity, rendering Sanger sequencing very laborious and expensive. As a proof of concept, we explored multiplex targeted high-throughput sequencing (HTS) as a fast and cost-efficient diagnostic method for individuals suffering from Mendelian cardiac disorders. We designed a DNA capture assay including all exons from 130...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Cardiomyopathy, Hypertrophic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MYBPC3 gene

Share to MYH7 gene

Share to High-Throughput Nucleotide Sequencing

Share to Long QT Syndrome

Share to Mutation

Source

Identifiers

PMID: 23590259
DOI: 10.1111/cge.12168

Genes

MYBPC3
MYH7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiplex targeted high-throughput sequencing for Mendelian cardiac disorders.PMID 23590259Read ↗

DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies.Semantic proximity Read ↗

Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy.Semantic proximity Read ↗

A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice.Semantic proximity Read ↗

Targeted Next-Generation Sequencing for the Molecular Genetic Diagnostics of CardiomyopathiesSemantic proximity Read ↗

Rapid molecular genetic diagnosis of hypertrophic cardiomyopathy by semiconductor sequencing.Semantic proximity Read ↗

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac DiseaseSemantic proximity Read ↗

Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing.Semantic proximity Read ↗

Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.Semantic proximity Read ↗

Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.Semantic proximity Read ↗

Molecular analysis of inherited cardiomyopathy using next generation semiconductor sequencing technologies.Semantic proximity Read ↗

A Variant Detection Pipeline for Inherited Cardiomyopathy-Associated Genes Using Next-Generation Sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.